•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Levi & Korsinsky has notified investors that it has commenced an investigation into GeneDx Holdings Corp. (NASDAQ: WGS) regarding potential violations of federal securities laws.
During GeneDx’s Q4 2025 earnings call on February 23, 2026, CFO Kevin Feeley told investors the company expected “adjusted net income positive for the full year and each individual quarter” of 2026.
GeneDx subsequently reported Q1 2026 adjusted EPS of -$0.28, compared with consensus expectations of -$0.01. In the same quarter, the company reported an adjusted net loss of $8.2 million, despite management having projected profitability.
Following the Q1 2026 results, the stock fell approximately 41% to 49%. The decline was attributed to the difference between the adjusted EPS figure of -$0.28 and the consensus expectation of -$0.01, which widened the gap between earlier guidance and subsequent results.
Levi & Korsinsky said that investors who suffered losses on GeneDx Holdings Corp. securities may explore a potential recovery under the federal securities laws. The firm indicated that Joseph E. Levi, Esq. can be contacted at jlevi@levikorsinsky.com or by calling (212) 363-7500.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
